SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Bayesian approach to stochastic cost-effectiveness analysis
7 references·16 citing·33 second hop
A Bayesian approach to stochastic cost-effectiveness analysis (1999)A Bayesian approach to stochastic cost-ef…Net Health Benefits (1998)Net Health BenefitsCost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis o…Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Cost effectiveness analysis o…Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Confidence intervals or surfa…Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)Pulling cost-effectiveness an…ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)ESTIMATING CONFIDENCE INTERVA…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Costs, effects and C/E‐ratios…Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Regression models for analyzi…Probabilistic sensitivity analysis in health economics (2011)Probabilistic sensitivity ana…Use of standardised outcome measures in adult mental health services (2006)Use of standardised outcome m…Information Created to Evade Reality (ICER) (2006)Information Created to Evade …Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)Incremental cost-effectivenes…Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence? (2005)Establishing the Cost-Effecti…Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models (2004)Assessing generalisability by…Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies (2003)Advantages of Using the Net-B…Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)Opportunity costs and uncerta…Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? (2002)Assessing and comparing costs…Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation (2002)Alternative decision modellin…Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (2001)Quantifying stochastic uncert…BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)BAYESIAN VALUE-OF-INFORMATION…Bayesian cost‐effectiveness analysis from clinical trial data (2001)Bayesian cost‐effectiveness a…Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane (2001)Affordability and cost‐effect…A framework for cost‐effectiveness analysis from clinical trial data (2001)A framework for cost‐effectiv…A Guide to Simulation (1983)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Handling Uncertainty in Cost-Effectiveness Models (2000)Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions (2004)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Cost-Effectiveness in Health and Medicine (1996)Patient-based health technology assessment: A vision of the future (2007)Cost-Effectiveness Thresholds: the Past, the Present and the Future (2018)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Information Value Theory (1966)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Markov Models in Medical Decision Making (1993)When should decision-analytic modeling be used in the economic evaluation of health care? (2003)Value of Information Analysis in Environmental Health Risk Management Decisions: Past, Present, and Future (2004)Value of Information Literature Analysis: A Review of Applications in Health Risk Management (2004)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Does equity in healthcare spending exist among Indian states? Explaining regional variations from national sample survey data (2017)Global treatment costs of breast cancer by stage: A systematic review (2018)Determinants of healthcare seeking and out-of-pocket expenditures in a “free” healthcare system: evidence from rural Malawi (2020)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Model of Complications of NIDDM: II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia (1997)Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods (1997)Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) (2003)Handling uncertainty when performing economic evaluation of healthcare interventions. (1999)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies (2002)
this work references cited by second hop

References

  • 1998Net Health Benefits1,104 cited
  • 1994Costs, effects and C/E‐ratios alongside a clinical trial963 cited
  • 1997Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation883 cited
  • 1998Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane397 cited
  • 1996ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL313 cited
  • 1998Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40302 cited
  • 1998Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40301 cited

Cited by

  • 2005Incremental cost-effectiveness ratios (ICERs): The silence of the lambda253 cited
  • 2001BAYESIAN VALUE-OF-INFORMATION ANALYSIS186 cited
  • 2011Regression models for analyzing costs and their determinants in health care: an introductory review176 cited
  • 2002Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation158 cited
  • 2006Use of standardised outcome measures in adult mental health services147 cited
  • 2011Probabilistic sensitivity analysis in health economics146 cited
  • 2003

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies
124 cited
  • 2005Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?121 cited
  • 2004Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models117 cited
  • 2002Opportunity costs and uncertainty in the economic evaluation of health care interventions115 cited
  • 2001Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses112 cited
  • 2001Bayesian cost‐effectiveness analysis from clinical trial data108 cited
  • 2001Affordability and cost‐effectiveness: decision‐making on the cost‐effectiveness plane106 cited
  • 2001A framework for cost‐effectiveness analysis from clinical trial data102 cited
  • 2002Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?100 cited
  • 2006Information Created to Evade Reality (ICER)96 cited